Based on the PREVENT risk calculator, researchers developed age- and sex-specific percentiles for 30-year absolute risk estimates for cardiovascular disease. Framing risk relative to peers by age and ...

Survivors with 10-year PREVENT absolute CVD risk defined as intermediate-high had 12.11-fold higher odds of developing CVD compared to survivors defined as lower risk. The PREVENT equation from the ...

Understanding worsening risks in a medical context can be challenging because advertisements often talk about relative risks, ...

EHR validation in 406,230 “relaxed” and 127,151 “strict” patients showed stable PREVENT discrimination across sexes, indicating resilience to real-world data incompleteness. Median race- and ...

Of 1035 screened abstracts and 301 full text CPGs, 47 CPGs were included: 23 on assessment/management of CVD risk in general, 13 on cholesterol, and 11 on hypertension. Additional file 1: Appendix A ...

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are associated ...

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition ...

Young men and minority patients with early-onset CRC in urban areas face higher CVD death risk, challenging assumptions about ...

Credit: Getty Images Steven Grinspoon, MD, and Matthew J Feinstein, MD, MSc, discuss ways to reduce CVD risk in patients with HIV. While further research is needed to elucidate the nature of CVD in ...

A new tool may help patients better understand their long-term cardiovascular risk, researchers said. Based on the standard PREVENT risk calculator, researchers developed population-based age- and sex ...